首页 | 本学科首页   官方微博 | 高级检索  
     


Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration
Authors:Luis Javier Hernández-Pastor  Ana Ortega  Alfredo García-Layana  Joaquín Giráldez
Affiliation:1. Department of Pharmacy, Clínica Universidad de Navarra, AV/Pio XII, 36, 31.008, Pamplona, Navarra, Spain
2. Department of Ophthalmology, Clínica Universidad de Navarra, AV/Pio XII, 36, 31.008, Pamplona, Navarra, Spain
Abstract:

Objective  

To assess the cost-effectiveness of ranibizumab compared with pegaptanib in the treatment of patients with minimally classic/occult neovascular age-related macular degeneration (AMD), from a societal perspective in Spain.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号